Published in Antimicrob Agents Chemother on September 01, 2002
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Toward an understanding of the correlates of protective immunity to HIV infection. Science (1996) 7.59
The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem (1989) 7.13
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med (1990) 5.55
Immunological memory. Adv Immunol (1993) 2.34
Zidovudine: five years later. Ann Intern Med (1992) 2.28
Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest (1993) 2.27
Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells. J Immunol (1981) 2.10
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood (1992) 1.79
Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today (1996) 1.75
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med (1994) 1.66
Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv Virus Res (1996) 1.48
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol (1988) 1.45
Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci (1997) 1.32
Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1989) 1.25
Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. AIDS Res Hum Retroviruses (1996) 1.14
AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest (1998) 1.13
Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones. J Immunol (1984) 1.06
Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science (1996) 1.06
Inhibition of immune functions by antiviral drugs. J Clin Invest (1991) 1.04
Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. J Acquir Immune Defic Syndr (1993) 1.01
Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1993) 1.00
Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: analysis by flow microfluorometry. J Immunol (1982) 0.96
Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein. AIDS Res Hum Retroviruses (1992) 0.95
In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent. Clin Exp Immunol (1993) 0.93
Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs. Int J Immunopharmacol (1997) 0.92
Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol (1992) 0.91
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity. Cancer Chemother Pharmacol (1995) 0.90
Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase. Biochem Pharmacol (1994) 0.87
Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.87
Viral and cellular factors for resistance against antiretroviral agents. Intervirology (1997) 0.87
P-glycoprotein (MDR 1 gene product) in cells of the immune system: its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol (1993) 0.87
Development and evaluation of a limiting dilution analysis technique that can discriminate in vivo alloactivated cytotoxic T lymphocytes from their naive CTL precursors. Transplantation (1989) 0.83
The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals. Cell Immunol (1991) 0.83
Zidovudine induces the expression of cellular resistance affecting its antiviral activity. AIDS Res Hum Retroviruses (1994) 0.83
A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment. Toxicol Appl Pharmacol (1989) 0.83
Immunotoxicity of AZT: inhibitory effect on thymocyte differentiation and peripheral T cell responsiveness to gp120 of human immunodeficiency virus. Toxicol Appl Pharmacol (1995) 0.81
The role of host immune responses in determining the outcome of HIV infection. Immunol Today (1996) 0.81
Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction. Transplantation (1988) 0.80
3'-Azido-3'-deoxythymidine inhibition of human lymphocyte cytolytic function in vitro. Biochem Pharmacol (1991) 0.79
AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter? Genetica (1995) 0.79
Failure of antiretroviral therapy: role of viral and cellular factors. Intervirology (1994) 0.79
Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacy. Antimicrob Agents Chemother (1996) 0.79
Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. Antiviral Res (1989) 0.78
AZT incorporation into mitochondria: study in a human myeloid cell line. DNA Cell Biol (1996) 0.78
Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells. Biochem Biophys Res Commun (1990) 0.78
Effects of 3'-azido-3'-deoxythymidine on the deoxynucleoside triphosphate pools of cultured human cells. Adv Exp Med Biol (1989) 0.77
Effect of zidovudine on the primary cytolytic T-lymphocyte response and T-cell effector function. Antimicrob Agents Chemother (2000) 0.76
AZT decreases rat myocardial cytochrome oxidase activity and increases beta-myosin heavy chain content. J Mol Cell Cardiol (1998) 0.76
Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol Rev (1995) 0.76
Bimanual assisted eyelid retraction technique for intravitreal injections. Retina (2013) 2.20
MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY. Retina (2016) 2.01
Surgical repair of macular fold after vitrectomy for bullous rhegmatogenous retinal detachment. Retina (2012) 1.99
Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc Res (2002) 1.49
Dose finding - a challenge in statistics. Biom J (2008) 1.44
Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol (2002) 1.35
Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res (2003) 1.35
Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol (2006) 1.26
Integration of tomato reproductive developmental landmarks and expression profiles, and the effect of SUN on fruit shape. BMC Plant Biol (2009) 1.19
The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunity. Theor Biol Med Model (2007) 1.14
Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J Immunol (2004) 1.13
Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol Biol Cell (2004) 1.09
Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol (2008) 1.07
Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol (2007) 1.06
Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Carcinogenesis (2012) 1.04
Applying the generalized partitioning principle to control the generalized familywise error rate. Biom J (2007) 0.99
Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1. PLoS One (2008) 0.98
Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant (2003) 0.95
Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema. Ophthalmic Surg Lasers Imaging (2009) 0.95
Ganoderma lucidum polysaccharides enhance CD14 endocytosis of LPS and promote TLR4 signal transduction of cytokine expression. J Cell Physiol (2007) 0.93
Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol (2013) 0.92
High-throughput screening of small molecules identifies hepcidin antagonists. Mol Pharmacol (2013) 0.91
Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts. J Immunol (2005) 0.89
Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. J Cell Physiol (2008) 0.89
Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. Am J Physiol Cell Physiol (2008) 0.88
Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages. Mol Pharmacol (2006) 0.88
Lentivirus-specific cytotoxic T-lymphocyte responses are rapidly lost in thymectomized cats infected with feline immunodeficiency virus. J Virol (2005) 0.86
Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant (2002) 0.85
Removal of posterior segment retained lens material using the OZil phacoemulsification handpiece versus Fragmatome during pars plana vitrectomy. Retina (2012) 0.84
Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors. Ophthalmology (2012) 0.82
Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina (2015) 0.82
High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant (2002) 0.81
En Face Optical Coherence Tomography Imaging of Deep Capillary Plexus Abnormalities in Paracentral Acute Middle Maculopathy. Ophthalmic Surg Lasers Imaging Retina (2015) 0.81
Quality and Diagnostic Utility of Mydriatic Smartphone Photography: The Smartphone Ophthalmoscopy Reliability Trial. Ophthalmic Surg Lasers Imaging Retina (2015) 0.80
The graft helps to define the character of the alloimmune response. Transpl Immunol (2002) 0.80
OUTCOMES OF RETINAL DETACHMENT REPAIR AFTER POSTERIOR OPEN GLOBE INJURY. Retina (2016) 0.80
Animal models of retroviral encephalopathies: feline model. Curr Protoc Neurosci (2002) 0.79
The need for veterinarians in biomedical research. J Vet Med Educ (2009) 0.79
Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Invest Ophthalmol Vis Sci (2004) 0.79
Contemporary Management of Rhegmatogenous Retinal Detachment Due to Giant Retinal Tears: A Consecutive Case Series. Ophthalmic Surg Lasers Imaging Retina (2015) 0.78
Allograft acceptance despite differential strain-specific induction of TGF-beta/IL-10-mediated immunoregulation. Am J Transplant (2002) 0.78
What's new in orthopaedic rehabilitation. J Bone Joint Surg Am (2011) 0.78
Panel forum on multiple comparison procedures: a commentary from a complex trial design and analysis plan. Biom J (2013) 0.78
Evaluation of bystander recruitment and cytotoxic functions of the IFN-gamma producing alloreactive CD8+ T cells in mice. Immunol Lett (2005) 0.78
MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Transplantation (2002) 0.77
Identification of a novel common proviral integration site, flit-1, in feline leukemia virus induced thymic lymphoma. Virology (2009) 0.77
Evaluation of immune regulation in transplant patients using the trans vivo delayed type hypersensitivity assay. Hum Immunol (2007) 0.77
In vivo expression of GFP transgene delivered via a replicating feline leukemia virus. Vet Microbiol (2005) 0.76
Reishi Protein LZ-8 Induces FOXP3(+) Treg Expansion via a CD45-Dependent Signaling Pathway and Alleviates Acute Intestinal Inflammation in Mice. Evid Based Complement Alternat Med (2013) 0.76
Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol (2015) 0.75
Reply: To PMID 23609121. Retina (2014) 0.75
Reply: To PMID 22869023. Retina (2013) 0.75
Expression of equine glucose transporter type 4 in skeletal muscle after glycogen-depleting exercise. Am J Vet Res (2005) 0.75
Iatrogrenic retinal breaks. Ophthalmology (2011) 0.75
Progress in the discovery and definition of monoclonal antibodies for use in feline research. Vet Immunol Immunopathol (2007) 0.75
Video Recording of Vitreous Tap and Intravitreal Antibiotic Injection From the Surgeon's Perspective. Retina (2015) 0.75
EN FACE VERSUS 12-LINE RADIAL OPTICAL COHERENCE TOMOGRAPHY SCAN PATTERNS FOR DETECTION OF MACULAR FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retin Cases Brief Rep (2017) 0.75
Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments. Ophthalmic Surg Lasers Imaging Retina (2020) 0.75
Evolution of immunosuppression in kidney transplantation: the Ohio State University experience. Clin Transpl (2005) 0.75
Using the partitioning principle to adaptively design dose-response studies. J Biopharm Stat (2006) 0.75
External Drainage of Subretinal Fluid During Vitrectomy for Rhegmatogenous Retinal Detachment. Retina (2019) 0.75
Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. J Ocul Pharmacol Ther (2014) 0.75
SHORT-TERM OUTCOMES OF HYBRID 23-, 25-, AND 27-GAUGE VITRECTOMY FOR COMPLEX DIABETIC TRACTIONAL RETINAL DETACHMENT REPAIR. Retin Cases Brief Rep (2017) 0.75
INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina (2015) 0.75
Mechanical actions of individual muscles at the human elbow joint and their roles in protecting/unloading the ulnar collateral ligament. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
COAGULASE-NEGATIVE STAPHYLOCOCCUS-INDUCED FROSTED BRANCH ANGIITIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION. Retin Cases Brief Rep (2016) 0.75
Monocular amaurosis fugax as the heralding symptom of vasovagal syncope. Heart Rhythm (2010) 0.75
What's new in orthopaedic rehabilitation. J Bone Joint Surg Am (2009) 0.75
Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal Detachment. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
What's new in orthopaedic rehabilitation. J Bone Joint Surg Am (2008) 0.75
Combined 27-Gauge Pars Plana Vitrectomy and Scleral Fixation of an Akreos AO60 Intraocular Lens Using Gore-Tex Suture. Retina (2016) 0.75
27-GAUGE VITRECTOMY WOUND INTEGRITY: A Randomized Pilot Study Comparing Angled Versus Straight Entry in Fluid-Filled Vitrectomized Eyes. Retina (2017) 0.75
Plenoptic Ophthalmoscopy: A Novel Imaging Technique. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
MINIMAL ENDOILLUMINATION LEVELS AND DISPLAY LUMINOUS EMITTANCE DURING THREE-DIMENSIONAL HEADS-UP VITREORETINAL SURGERY. Retina (2016) 0.75
Partition testing in dose-response studies with multiple endpoints. Pharm Stat (2007) 0.75
Topical aqueous suppression does not significantly affect duration of intraocular gas tamponade after vitrectomy. Retina (2012) 0.75
Poorer Outcomes in Real-World Studies of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology (2020) 0.75
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR). Retina (2017) 0.75